Alnylam Pharmaceuticals (DUL.MU) Q2 2026 Earnings

30AprConfirmed
Q1 2026
Next
0.69
0.79
0.88
0.97

Details

Expected EPS
0.76453585
Actual EPS
N/A
Surprise EPS
-0.76
Surprise Percent
+100%

Description

Alnylam Pharmaceuticals (DUL.MU) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts